Recursion Pharmaceuticals, Inc. RXRX Invested capital
Discontinued — last reported Q1 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Recursion Pharmaceuticals, Inc.’s reported figures.
The official record: Recursion Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Recursion Pharmaceuticals, Inc.'s invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Recursion Pharmaceuticals, Inc.'s invested capital?
- Recursion Pharmaceuticals, Inc. (RXRX) reported invested capital of $448.16M in Q1 2026.
- How has Recursion Pharmaceuticals, Inc.'s invested capital changed year-over-year?
- Recursion Pharmaceuticals, Inc.'s invested capital decreased by 17.4% year-over-year, from $542.3M to $448.16M.
- What is the long-term trend for Recursion Pharmaceuticals, Inc.'s invested capital?
- Over 5 years (2020 to 2025), Recursion Pharmaceuticals, Inc.'s invested capital has grown at a 0.5% compound annual growth rate (CAGR), from -$462.04M to $473.25M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).